Growth Factors

Original Editor - Lucinda hampton

Top Contributors - Lucinda hampton and Sehriban Ozmen  

Introduction[edit | edit source]

Colon cancer cells acquire the ability to migrate and become invasive.

Growth factors, now considered as a subset of cytokines, are the diffusible signaling proteins that stimulate cell growth, differentiation, survival, inflammation, and tissue repair. They can be secreted by neighboring cells, distant tissues and glands, or cancer cells themselves. Normal cells show a requirement for several growth factors to maintain proliferation and viability. Growth advantage is often found for the cells which secrete a growth factor.[1]

  1. Growth factors are important in both normal physiological processes for example wound healing and abnormal processes for example cancer and diabetic retinopathy[2].
  2. The potential use of growth factors for therapeutic applications is growing

Sub Heading 2[edit | edit source]

Therapeutic Use[edit | edit source]

Plasma Rich Plasma Re-injected into the target site.

Several growth factors are used therapeutically. Examples include

  • A swift development in the use of growth factors for accelerated healing of injury is occurring currently. Growth factors that mediate the processes needed for repair of soft tissues have been shown in animal studies to bring direct benefits in terms of accelerated healing. Platelets contain growth factors in their α-granules ( for example insulin-like growth factor-1, basic fibroblast growth factor, platelet-derived growth factor, epidermal growth factor, vascular endothelial growth factor) and these are used utilised today in techniques are known as platelet-rich plasma, autologous blood injections and autologous conditioned serum. These techniques has been studied clinically in humans on a small scale but results to date are promising for a speedier return to play following muscle and particularly tendon injury. [3]
  • Erythropoietin, which stimulates the growth of red blood cells, is used to treat anemia associated with chronic kidney failure, cancer chemotherapy, and zidovudine (AZT) therapy in AIDS patients.
  • Granulocyte colony-stimulating factor (G-CSF; filgrastim) and granulocyte-macrophage colony-stimulating factor (GM-CSF; sargramostim) are used to stimulate the production of white blood cells in patients with cancer. [4]
  • Epidermal Growth Factor can be used for patients with recalcitrant skin wounds and skin aging, as it is an effective and specific mitogenic factor for the skin[5].
  • Vascular endothelial growth factor (VEGF, VEGF-A) is a major regulator of physiological and pathological angiogenesis. variuos VEGF inhibitors have been approved by the FDA for the treatment of advanced cancer and neovascular age-related macular degeneration.[6]
  • Nerve growth factor (NGF) have long been regarded as potential drugs to combat acute and chronic neurodegenerative diseases (Alzheimer’s disease, AD; and Parkinson’s disease, PD) and brain injuries (perinatal hypoxia/ischemia, traumatic brain, and spinal cord injury), and also retinopathies, optic nerve degeneration, and peripheral neuropathies associated with diabetes and HIV. However to date their clinical application has been impeded by their unforeseen side effects, as well as by trouble of dosing and administration strategies.[7]

Sub Heading 3[edit | edit source]

Resources[edit | edit source]

  • bulleted list
  • x

or

  1. numbered list
  2. x

References[edit | edit source]

  1. Sinobiological What are growth factors Available: https://www.sinobiological.com/resource/cytokines/what-are-growth-factors (accessed 13.8.2022)
  2. Stone WL, Leavitt L, Varacallo M. Physiology, growth factor. Available:https://www.ncbi.nlm.nih.gov/books/NBK442024/ (accessed 13.8.2022)
  3. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. British journal of sports medicine. 2008 May 1;42(5):314-20. Available: https://bjsm.bmj.com/content/42/5/314.short(accessed 13.8.2022)
  4. Brittanica Growth Factor Available:https://www.britannica.com/science/growth-factor (accessed 13.8.2022)
  5. Miller-Kobisher B, Suárez-Vega DV, de Maldonado GJ. Epidermal growth factor in aesthetics and regenerative medicine: Systematic review. Journal of Cutaneous and Aesthetic Surgery. 2021 Apr;14(2):137. Available:https://pubmed.ncbi.nlm.nih.gov/34566354/ (accessed 13.8.2022)
  6. Ferrara N. Vascular endothelial growth factor. Arteriosclerosis, thrombosis, and vascular biology. 2009 Jun 1;29(6):789-91. Available:https://www.ahajournals.org/doi/10.1161/atvbaha.108.179663 (accessed 13.8.2022)
  7. Alastra G, Aloe L, Baldassarro VA, Calzà L, Cescatti M, Duskey JT, Focarete ML, Giacomini D, Giardino L, Giraldi V, Lorenzini L. Nerve growth factor biodelivery: a limiting step in moving toward extensive clinical application?. Frontiers in Neuroscience. 2021;15:879. Available:https://www.frontiersin.org/articles/10.3389/fnins.2021.695592/full (accessed 13.8.2022)